Kissimmee, FL (PRWEB) April 16, 2012
Dr. Gabriel Buendía of the Médico Teknon Center (Barcelona, Spain) and Dr. Steven Shapiro of Gardens Dermatology and Cosmetic Surgery Center (Boca Raton, FL) will present clinical research on the safety and efficacy of TriPollar—the world's most advanced radiofrequency (RF) technology—at the 32nd Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) at the Gaylord Palms Resort and Convention Center from April 18 through April 22. The innovative 3rd generation TriPollar RF technology is now available in the U.S. via a device called Apollo through an exclusive partnership between Pollogen, a global leader in the medical aesthetics market and member of the ASLMS Industry Advisory Council, and Lumiere Medical, a premier U.S. distributor of cutting-edge, clinically-validated technologies.
On Saturday, April 21 at 5:30 p.m., Dr. Buendía will present an “optical measurements-based objective assessment for the characterization of grade II and grade III cellulite response on women’s thighs to a six week-long multipolar radiofrequency combined with muscle dynamic activation treatment.” On Sunday, April 22 at 11:00 a.m., Dr. Shapiro will lecture on the safety and efficacy of the Apollo system for wrinkle reduction.
The Apollo powered by TriPollar is FDA-cleared for the non-invasive treatment of mild to moderate facial wrinkles. The 30-minute, no-downtime procedure has been globally embraced for its off-label use on the body with great success in treating cellulite and circumferential reduction. Unlike its competitors, the Apollo is completely pain-free. TriPollar also differs from other technologies because it allows patients of all skin types to achieve measurable anti-aging results.
Patients benefit from both visible immediate and long-term results. The immediate effects include a smoother, tightened appearance and texture. Most clients realize the optimal outcome at the conclusion of the full treatment course—a recommended six to eight sessions—with a noticeable reduction in wrinkles and fine lines, body contouring and lifting of the treatment area, in addition to improved skin tone and texture.
The safety and efficacy of TriPollar treatments have been proven in multiple clinical studies and published in eight peer reviewed articles. A recent U.S. clinical study showed a 97% improvement following a full series of treatments, and 100% of the patients reported that they were satisfied with their results.
For more information, please visit http://www.pollogen.com/Tripollar-RF-Technology/Tripollar-RF-Technology.html or http://www.lumieremed.com.
Pollogen Ltd. is a global leader in the medical aesthetic market providing innovative, safe and effective solutions that enhance and expand the practices of medical aesthetic professionals. The company offers products to address a range of skin treatments under the industry’s three premier brands: TriPollar®, TriLipo® and TriFractional™. Pollogen offers a full line of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for circumference reduction, cellulite reduction and skin tightening. The company’s medical aesthetic devices, Maximus, Apollo, and Regen XL offer customers clinically-proven, safe and effective anti-aging lunchtime beauty treatments that deliver immediate and long-lasting results. With a distribution network in over 60 countries, Pollogen is providing innovative solutions to medical professionals globally.
About Lumiere Medical
Lumiere Medical, the premier U.S. distributor of innovative, science-based, clinically validated technologies, presents new revenue opportunities for its customers while providing results which consistently deliver high patient satisfaction. The exclusive U.S. distributor for Pollogen Ltd., Lumiere has recently added the Apollo TriPollar RF device to its distribution network, offering safe and effective anti-aging treatments with both immediate and long-lasting results.